Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medinotec (MDNC) Return on Sales (2022 - 2025)

Medinotec's Return on Sales history spans 4 years, with the latest figure at 0.16% for Q4 2025.

  • For Q4 2025, Return on Sales rose 4.0% year-over-year to 0.16%; the TTM value through Nov 2025 reached 0.38%, up 25.0%, while the annual FY2025 figure was 0.41%, 45.0% up from the prior year.
  • Return on Sales reached 0.16% in Q4 2025 per MDNC's latest filing, up from 0.11% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.87% in Q1 2025 to a low of 1.61% in Q3 2022.
  • Average Return on Sales over 4 years is 0.06%, with a median of 0.06% recorded in 2024.
  • The largest YoY upside for Return on Sales was 149bps in 2023 against a maximum downside of -30bps in 2023.
  • A 4-year view of Return on Sales shows it stood at 0.06% in 2022, then tumbled by -534bps to 0.25% in 2023, then surged by 149bps to 0.12% in 2024, then skyrocketed by 31bps to 0.16% in 2025.
  • Per Business Quant, the three most recent readings for MDNC's Return on Sales are 0.16% (Q4 2025), 0.11% (Q3 2025), and 0.25% (Q2 2025).